What happened

The government backed the Commission’s recommendations and opened AI Airlock Phase 3, emphasizing lifecycle oversight and postmarket surveillance.

Why it matters

One-time testing cannot reveal every issue that appears after a clinical tool enters service.

Key numbers & facts

  • 44 recommendations accepted; applicant webinar scheduled for October 22.

Practical implications

  • Eligible developers can review sandbox criteria and prepare evidence on monitoring and managing changes.

Likely future impact

Analysis, not a confirmed outcome.

  • A full implementation roadmap is expected by spring 2027.

Evidence

  • MHRA, published 2026-10-06; direct source linked below.

What remains uncertain

  • Acceptance of recommendations does not mean every reform is already implemented.